AlphaFold predicted structure
UPB1 · Q9UBR1

Mean pLDDT
97.0/ 100
Very high
384 residues
Confidence breakdown
- Very high(≥ 90)97%
- Confident(70–90)2%
- Low(50–70)1%
- Very low(< 50)1%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
beta-ureidopropionase 1
Annotations refreshed 9 hours ago.
Diagnostic Grade (Green)
Likely inborn error of metabolism
BIALLELIC, autosomal or pseudoautosomalIntellectual disability
BIALLELIC, autosomal or pseudoautosomalUndiagnosed metabolic disorders
BIALLELIC, autosomal or pseudoautosomalbeta-ureidopropionase deficiency
hereditary disease
acne
metabolic disease
Abnormal urine sodium concentration
hepatocellular carcinoma
coronary artery disorder
colorectal cancer
neoplasm
hyperinsulinemic hypoglycemia, familial, 4
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Beta-ureidopropionase
Catalyzes a late step in pyrimidine degradation (PubMed:22525402, PubMed:24526388). Converts N-carbamoyl-beta-alanine (3-ureidopropanoate) into beta-alanine, ammonia and carbon dioxide (PubMed:10415095, PubMed:10542323, PubMed:11508704, PubMed:22525402, PubMed:24526388, PubMed:29976570). Likewise, converts N-carbamoyl-beta-aminoisobutyrate (3-ureidoisobutyrate) into beta-aminoisobutyrate, ammonia and carbon dioxide (Probable)
UPB1 · Q9UBR1

Mean pLDDT
97.0/ 100
Very high
384 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0